Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)
haemophilus influenzae type b conjugate vaccine (PedvaxHIB) (1 trial)
hib vaccine (1 trial)
inactivated SARS-Cov-2 vaccine (5 trials)
mcv-ac vaccine group (1 trial)
mcv-acyw135 vaccine (1 trial)
minhai-hib (1 trial)
mpv-a (1 trial)
mpv-acyw135 (1 trial)
pneumococcal 7-valent conjugate vaccine (prevnar) (1 trial)
quadrivalent groups a, c, y, and w-135 meningococcal vaccine (Menomune-A/C/Y/W-135) (1 trial)
rabies vaccine (purified chick embryo cell vaccine) (RabAvert) (2 trials)
ipv (2 trials)
Haemophilus Infections (Phase 3)
Influenza, Human (Phase 3)
Meningitis (Phase 3)
Pneumonia (Phase 3)
Postpoliomyelitis Syndrome (Phase 2)
Rabies (Phase 3)
Trials (14 total)
Trial APIs (13 total)